Skip to main content

People in the News: Mar 16, 2011


Former chief financial officer of Myriad Genetics, Jay Moyes, has been appointed to the board of directors at Integrated Diagnostics. After his tenure at Myriad, Moyes served as chief financial officer of XDx, a molecular diagnostic company. Currently, he is director and chair of the audit committees of both Osiris Therapeutics and BioCardia.

Former vice president of sales at Myriad, Mark Willig, has been named executive vice president of North American sales at Agendia. Willig has held a number of leadership positions within the healthcare industry, including general manager and chief commercial officer at Exiqon, vice president of global sales for Thermo Fisher's anatomic pathology business unit, executive vice president of sales and marketing at Specialty Labs, as well as 12 years in commercial roles at Abbott Diagnostics. He holds a BS from the University of Missouri.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.